By creating a free Inderes account, you get access to Inderes analysis, you can order the popular morning review and follow companies and discussions that interest you.
Already have an account?
Follow this company like 8402 other investors.
This morning, Taaleri announced first closing of its first bioindustry fund at targeted EUR 80m. The company continues fundraising backed up by strong demand.
Based on segment reporting, Taaleri reported Q1 sales of EUR 7.2m and operating profit of EUR -0.7m, clearly above Refinitiv consensus expectations.
Taaleri reported Q1 EBIT of EUR -0.6m, coming clearly above Refinitiv consensus at EUR -4.3m. Total income from segment reporting was EUR 7.2m above Nordea estimate of EUR 0m. Recurring revenues were EUR 9.3m in Q1, missing our estimate by 6%.
We believe Q1 will be negatively affected by Garantia's investment operations, given the current market turmoil and its relatively high exposure to fixed-income products.
Taaleri announced that it will record an estimated earnout of EUR 6.7m in Q2 from the Finsilva holding sold in 2016.
Taaleri is selling its stake in Ficolo and exiting Taaleri Datacenter, through which Taaleri and its co-investors own a total of 47% of Ficolo.
Taaleri reported Q4 EBIT of EUR 14.7m, coming 8% below Refinitiv consensus. However, when adjusting for non-recurring personnel costs, Q4 EBIT was 3% above consensus.
Taaleri reported Q4 EBIT of EUR 14.7m, coming -8% and +1% versus Refinitiv consensus and Nordea, respectively.
Taaleri is a leading Nordic investment and asset manager focusing on sustainability. The company is in a transformational period after divesting its wealth management arm in April.
Q1 21 provided a first glimpse of the new Taaleri, as the transaction with Aktia regarding Taaleri’s Wealth Management operations was completed at the end of April 2021.